As a key anti-tumor immune component of cancer-specific T cells, CD8+ T cells contact physically with malignant tumor cells and cause the death of tumor cells by activating their intracellular signals during tumor immunity [39,40]. This evidence concerns the gene CD8A and neoplasm.